Dr. Craig Koniver

There's these bioregulator peptides, which were developed by this Russian scientist, last name Korvinson, I think. Done a lot of research, actually. There's published research about it. I think Penelon's one of the ones that... They say we'll survive the stomach acid and get through the gut and be absorbed. So I think that's true. We've always used it as injectable.

There's these bioregulator peptides, which were developed by this Russian scientist, last name Korvinson, I think. Done a lot of research, actually. There's published research about it. I think Penelon's one of the ones that... They say we'll survive the stomach acid and get through the gut and be absorbed. So I think that's true. We've always used it as injectable.

And I tend to like injectable things for the bioavailability. So yeah, but to your point, I think people can. Those are going to be harder and harder to find, actually. It's probably easier to find an injectable pineal than an oral one.

And I tend to like injectable things for the bioavailability. So yeah, but to your point, I think people can. Those are going to be harder and harder to find, actually. It's probably easier to find an injectable pineal than an oral one.

And I tend to like injectable things for the bioavailability. So yeah, but to your point, I think people can. Those are going to be harder and harder to find, actually. It's probably easier to find an injectable pineal than an oral one.

Yeah. And researching, right. Making sure that what you're taking is, is legit. A lot of illegitimacy out there.

Yeah. And researching, right. Making sure that what you're taking is, is legit. A lot of illegitimacy out there.

Yeah. And researching, right. Making sure that what you're taking is, is legit. A lot of illegitimacy out there.

Big money. The concerning part about the GLP-1s is, to me, is what we're starting to see. They've been able to be compounded because there was a shortage. And the way it works with compounding pharmacies is because those are brand – named drugs, and they're not patented for the peptide, right? They're patented for the delivery system, which is the pen, which most people don't realize.

Big money. The concerning part about the GLP-1s is, to me, is what we're starting to see. They've been able to be compounded because there was a shortage. And the way it works with compounding pharmacies is because those are brand – named drugs, and they're not patented for the peptide, right? They're patented for the delivery system, which is the pen, which most people don't realize.

Big money. The concerning part about the GLP-1s is, to me, is what we're starting to see. They've been able to be compounded because there was a shortage. And the way it works with compounding pharmacies is because those are brand – named drugs, and they're not patented for the peptide, right? They're patented for the delivery system, which is the pen, which most people don't realize.

And they've been able to be compounded and then way more affordable because they're compounded. And there is rumors that the pharmaceutical companies now have supply back. They'll come back and they will remove the ability to allow these peptides to be compounded, which means we'll have to stick to traditional dosages and people will lose access because they're going to be way more expensive.

And they've been able to be compounded and then way more affordable because they're compounded. And there is rumors that the pharmaceutical companies now have supply back. They'll come back and they will remove the ability to allow these peptides to be compounded, which means we'll have to stick to traditional dosages and people will lose access because they're going to be way more expensive.

And they've been able to be compounded and then way more affordable because they're compounded. And there is rumors that the pharmaceutical companies now have supply back. They'll come back and they will remove the ability to allow these peptides to be compounded, which means we'll have to stick to traditional dosages and people will lose access because they're going to be way more expensive.

I mean, they are. If your insurance doesn't cover it, $1,500 a month for most people. Very expensive. That's a lot of money. Yeah. For a lot of people, that's rent and more. So I'm hopeful that doesn't happen. But that's in the works. That's in the works. And that would be a huge shame. And again, I'm not a pessimist by any means. I'm a perpetual optimist.

I mean, they are. If your insurance doesn't cover it, $1,500 a month for most people. Very expensive. That's a lot of money. Yeah. For a lot of people, that's rent and more. So I'm hopeful that doesn't happen. But that's in the works. That's in the works. And that would be a huge shame. And again, I'm not a pessimist by any means. I'm a perpetual optimist.

I mean, they are. If your insurance doesn't cover it, $1,500 a month for most people. Very expensive. That's a lot of money. Yeah. For a lot of people, that's rent and more. So I'm hopeful that doesn't happen. But that's in the works. That's in the works. And that would be a huge shame. And again, I'm not a pessimist by any means. I'm a perpetual optimist.

So we'll just make sure that stays this way. But again, if it does happen, we'll get creative and go other routes as well.

So we'll just make sure that stays this way. But again, if it does happen, we'll get creative and go other routes as well.

So we'll just make sure that stays this way. But again, if it does happen, we'll get creative and go other routes as well.